282 related articles for article (PubMed ID: 37256065)
21. Serum response factor accelerates the high glucose-induced Epithelial-to-Mesenchymal Transition (EMT) via snail signaling in human peritoneal mesothelial cells.
He L; Lou W; Ji L; Liang W; Zhou M; Xu G; Zhao L; Huang C; Li R; Wang H; Chen X; Sun S
PLoS One; 2014; 9(10):e108593. PubMed ID: 25303231
[TBL] [Abstract][Full Text] [Related]
22. Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling.
Huang Q; Xiao R; Lu J; Zhang Y; Xu L; Gao J; Sun J; Wang H
Front Pharmacol; 2022; 13():973182. PubMed ID: 36210850
[No Abstract] [Full Text] [Related]
23. A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells.
Liu H; Peng Y; Liu F; Li J; Chen X; Liu Y; Zhang H
Cell Biol Int; 2007 May; 31(5):508-15. PubMed ID: 17196403
[TBL] [Abstract][Full Text] [Related]
24. Curcumin suppresses epithelial-to-mesenchymal transition of peritoneal mesothelial cells (HMrSV5) through regulation of transforming growth factor-activated kinase 1 (TAK1).
Zhao JL; Guo MZ; Zhu JJ; Zhang T; Min DY
Cell Mol Biol Lett; 2019; 24():32. PubMed ID: 31143210
[TBL] [Abstract][Full Text] [Related]
25. Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure.
López-Cabrera M; Aguilera A; Aroeira LS; Ramírez-Huesca M; Pérez-Lozano ML; Jiménez-Heffernan JA; Bajo MA; del Peso G; Sánchez-Tomero JA; Selgas R
Perit Dial Int; 2006; 26(1):26-34. PubMed ID: 16538870
[TBL] [Abstract][Full Text] [Related]
26. The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.
Fan YP; Hsia CC; Tseng KW; Liao CK; Fu TW; Ko TL; Chiu MM; Shih YH; Huang PY; Chiang YC; Yang CC; Fu YS
Stem Cells Transl Med; 2016 Feb; 5(2):235-47. PubMed ID: 26718649
[TBL] [Abstract][Full Text] [Related]
27. CXCR4-Receptor-Targeted Liposomes for the Treatment of Peritoneal Fibrosis.
Asifullah K; Zhou Z; He W; Gao K; Khan MW; Faisal R; Muhammad H; Sun M
Mol Pharm; 2019 Jun; 16(6):2728-2741. PubMed ID: 31070930
[TBL] [Abstract][Full Text] [Related]
28. Inflammation, neoangiogenesis and fibrosis in peritoneal dialysis.
de Lima SM; Otoni A; Sabino Ade P; Dusse LM; Gomes KB; Pinto SW; Marinho MA; Rios DR
Clin Chim Acta; 2013 Jun; 421():46-50. PubMed ID: 23466603
[TBL] [Abstract][Full Text] [Related]
29. ST2 blockade mitigates peritoneal fibrosis induced by TGF-β and high glucose.
Kim YC; Kim KH; Lee S; Jo JW; Park JY; Park MS; Tsogbadrakh B; Lee JP; Lee JW; Kim DK; Oh KH; Jang IJ; Kim YS; Cha RH; Yang SH
J Cell Mol Med; 2019 Oct; 23(10):6872-6884. PubMed ID: 31397957
[TBL] [Abstract][Full Text] [Related]
30. SPHK1-induced autophagy in peritoneal mesothelial cell enhances gastric cancer peritoneal dissemination.
Yin S; Miao Z; Tan Y; Wang P; Xu X; Zhang C; Hou W; Huang J; Xu H
Cancer Med; 2019 Apr; 8(4):1731-1743. PubMed ID: 30791228
[TBL] [Abstract][Full Text] [Related]
31. RhoA/Rho-kinase triggers epithelial-mesenchymal transition in mesothelial cells and contributes to the pathogenesis of dialysis-related peritoneal fibrosis.
Wang Q; Yang X; Xu Y; Shen Z; Cheng H; Cheng F; Liu X; Wang R
Oncotarget; 2018 Mar; 9(18):14397-14412. PubMed ID: 29581852
[TBL] [Abstract][Full Text] [Related]
32. Twist contributes to proliferation and epithelial-to-mesenchymal transition-induced fibrosis by regulating YB-1 in human peritoneal mesothelial cells.
He L; Che M; Hu J; Li S; Jia Z; Lou W; Li C; Yang J; Sun S; Wang H; Chen X
Am J Pathol; 2015 Aug; 185(8):2181-93. PubMed ID: 26055210
[TBL] [Abstract][Full Text] [Related]
33. Peritoneal fibrosis intervention.
Kaneko K; Hamada C; Tomino Y
Perit Dial Int; 2007 Jun; 27 Suppl 2():S82-6. PubMed ID: 17556336
[TBL] [Abstract][Full Text] [Related]
34. miR-15a-5p suppresses inflammation and fibrosis of peritoneal mesothelial cells induced by peritoneal dialysis via targeting VEGFA.
Shang J; He Q; Chen Y; Yu D; Sun L; Cheng G; Liu D; Xiao J; Zhao Z
J Cell Physiol; 2019 Jun; 234(6):9746-9755. PubMed ID: 30362573
[TBL] [Abstract][Full Text] [Related]
35. The Role of Cathepsin B in Peritoneal Fibrosis due to Peritoneal Dialysis.
Sung SA; Kim DH; Oh KH; Han SY; Han KH
Int J Nephrol; 2019; 2019():4150656. PubMed ID: 31815017
[TBL] [Abstract][Full Text] [Related]
36. A Review on Major Pathways Leading to Peritoneal Fibrosis in Patients Receiving Continuous Peritoneal Dialysis.
Taheri S; Thiagaraj SS; Shukla TS; Gutlapalli SD; Farhat H; Muthiah K; Pallipamu N; Hamid P
Cureus; 2022 Nov; 14(11):e31799. PubMed ID: 36579194
[TBL] [Abstract][Full Text] [Related]
37. PPARγ alleviates peritoneal fibrosis progression along with promoting GLUT1 expression and suppressing peritoneal mesothelial cell proliferation.
Feng J; Lu M; Li W; Li J; Meng P; Li Z; Gao X; Zhang Y
Mol Cell Biochem; 2022 Jul; 477(7):1959-1971. PubMed ID: 35380292
[TBL] [Abstract][Full Text] [Related]
38. Preserving the peritoneal membrane in long-term peritoneal dialysis patients.
Ditsawanon P; Aramwit P
J Clin Pharm Ther; 2015 Oct; 40(5):508-516. PubMed ID: 26280248
[TBL] [Abstract][Full Text] [Related]
39. A pathogenetic role for M1 macrophages in peritoneal dialysis-associated fibrosis.
Li Q; Zheng M; Liu Y; Sun W; Shi J; Ni J; Wang Q
Mol Immunol; 2018 Feb; 94():131-139. PubMed ID: 29306153
[TBL] [Abstract][Full Text] [Related]
40. Relationship between plasminogen activator inhibitor-1 gene alterations and fibrosis in peritoneal dialysis patients.
Onur Cura D; Yildiz S; Ataman E; Ersan S; Tanrisev M; Ulgenalp A; Camsari T; Ercal D
Ther Apher Dial; 2021 Feb; 25(1):97-102. PubMed ID: 32301223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
